Nucleonics
Langhorne, Pennsylvania, United States
About Nucleonics
Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $51.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2004)
- Website: nucleonicsinc.com
- Phone: +1 408-780-0908
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/nucleonics-2470554 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.